This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Lakehead University directory, so their courses may be missing. Find their university profile.
Latest papers
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer.
Bioorganic chemistry · 2026
Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer.
ChemMedChem · 2024
Low-cost target system for neutron activation using a medical cyclotron. Application to the non-destructive analysis of gold and silver.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · 2022 · first author
Latest funding
- $96,000
Radiochemical methods for labeling and isotope production
NSERC · 2021 · Principal investigator
- $39,451
A Microwave System for Medicinal Chemistry and Radiochemistry Research
NSERC · 2021 · Co-investigator
- $12,500
Radiochemical methods for labeling and isotope production
NSERC · 2021 · Principal investigator
6 publications.
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer.
Liu W, Mousa AAK, Dayer G, Hopkins AM, Campbell M, Mao Y, Jiang ZH, Lees SJ, Ramachandran R, Hou J
Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer.
Liu W, Mousa AAK, Hopkins AM, Wu YF, Thu KL, Campbell M, Lees SJ, Ramachandran R, Hou J
Low-cost target system for neutron activation using a medical cyclotron. Application to the non-destructive analysis of gold and silver.
Campbell M, Tikka A
Highly enantioselective (-)-sparteine-mediated lateral metalation-functionalization of remote silyl protected ortho-ethyl N,N-dialkyl aryl O-carbamates.
Fässler J, McCubbin JA, Roglans A, Kimachi T, Hollett JW, Kunz RW, Tinkl M, Zhang Y, Wang R, Campbell M, Snieckus V
Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging.
Bates D, Abraham S, Campbell M, Zehbe I, Curiel L
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions.
Zehbe I, Richard C, Lee KF, Campbell M, Hampson L, Hampson IN
Radiochemical methods for labeling and isotope production
Principal investigators: Campbell, Michael
Keywords: f-18; au-198; radolabeling; neutron activation; solid phase synthesis; si-31
A Microwave System for Medicinal Chemistry and Radiochemistry Research
Principal investigators: Hou, Jinqiang
Radiochemical methods for labeling and isotope production
Principal investigators: Campbell, Michael
Neutron activation analysis of precious metals using a medical cyclotron as the neutron source****
Principal investigators: Campbell, Michael
Development and optimization of resin based radionuclidic generators
Principal investigators: Campbell, Michael
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Rithwik Ramachandran and Jinqiang Hou: 3 shared papers
- Ingeborg Zehbe and Michael Campbell: 2 shared papers
- Rithwik Ramachandran and Michael Campbell: 2 shared papers
- Jinqiang Hou and Michael Campbell: 2 shared papers
- Rithwik Ramachandran and Zi-Hua Jiang: 1 shared paper
- Victor Snieckus and Michael Campbell: 1 shared paper
- Zi-Hua Jiang and Jinqiang Hou: 1 shared paper
- Zi-Hua Jiang and Michael Campbell: 1 shared paper
- Chemistry
- Biology
- Physiology and Pharmacology
- Head Office
Co-authors at Lakehead University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.